GO:0006541 L-glutamine metabolic process: Cancer Metabolism Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006541 (L-glutamine metabolic process) describes the chemical reactions and pathways involving glutamine, a conditionally essential amino acid and central nitrogen donor.
• Glutamine fuels cancer cell proliferation through glutaminolysis, supporting ATP production, redox balance, and macromolecular synthesis [1,2].
• Glutaminolysis and transferrin receptor regulation link glutamine metabolism to ferroptosis, a non-apoptotic iron-dependent cell death pathway.
• Hyperpolarized 13C/15N-labeled glutamine enables real-time in vivo annotation of glutamine utilization and downstream metabolic fluxes.
• Glutamine metabolism is altered in diabetes and other metabolic disorders, with tissue-specific responses in liver and other organs.
• CRISPR knockout, knock-in, and overexpression models are essential for dissecting causal roles of GLS, GLUD1, ASNS, and other glutamine pathway genes [1,2].
Description
L-glutamine metabolic process (GO:0006541) encompasses the chemical reactions and pathways involving glutamine, 2-amino-4-carbamoylbutanoic acid, as defined by the Gene Ontology. Glutamine is the most abundant free amino acid in circulation and serves as a critical nitrogen donor, carbon source, and signaling molecule in mammalian cells [1,2]. Its metabolism is central to cancer biology, immune function, and metabolic disorders, making it a high-priority research area [1,2]. The pathway includes glutamine uptake, deamidation to glutamate, and subsequent oxidation or transamination, collectively termed glutaminolysis. Beyond cancer, glutamine metabolism is relevant to diabetes, ferroptosis, and industrial biotechnology [3,4,5,7]. Understanding the genes and regulatory mechanisms of GO:0006541 is essential for developing targeted therapies and metabolic engineering strategies [1,2,5].
L-glutamine metabolic process At A Glance
| GO ID | GO:0006541 |
|---|---|
| GO term | L-glutamine metabolic process |
| Ontology | biological_process |
| Synonym | glutamine metabolism |
| Definition | The chemical reactions and pathways involving glutamine, 2-amino-4-carbamoylbutanoic acid. |
| Major function | Nitrogen donation, carbon fueling, redox homeostasis, and macromolecular synthesis |
| Key enzymes | GLS, GLUD1, GLUL, ASNS, GOT1, GOT2, and transporters SLC1A5, SLC7A5 |
| Disease relevance | Cancer, diabetes, ferroptosis, and metabolic disorders |
| Research methods | CRISPR screens, metabolomics, hyperpolarized 13C/15N imaging, and stable isotope tracing |
What Is GO:0006541?
GO:0006541, L-glutamine metabolic process, is defined as the chemical reactions and pathways involving glutamine, 2-amino-4-carbamoylbutanoic acid. This biological process includes glutamine synthesis, transport, and catabolism, with glutaminolysis being a key catabolic route that converts glutamine to glutamate, alpha-ketoglutarate, and ammonia [1,2]. The term is synonymous with glutamine metabolism and is distinct from related processes such as glutamate metabolism or nitrogen compound metabolism.
Why Is L-glutamine metabolic process Important in Cell Biology?
L-glutamine metabolic process is a central hub of cellular metabolism, providing nitrogen for nucleotide and amino acid synthesis, carbon for the TCA cycle, and precursors for glutathione [1,2]. Its dysregulation is a hallmark of many cancers, where glutamine addiction supports rapid proliferation and survival under stress [1,2]. Moreover, glutamine metabolism intersects with ferroptosis, a form of regulated cell death with therapeutic potential. In diabetes, altered glutamine handling in liver and other tissues contributes to metabolic dysfunction. Industrial production of L-glutamine also relies on metabolic engineering of this pathway [4,5]. Thus, GO:0006541 is a high-value target for both basic research and translational applications.
• Glutamine is the most abundant circulating amino acid and a major nitrogen donor for biosynthetic reactions.
• Glutaminolysis supports cancer cell proliferation by replenishing TCA cycle intermediates and generating NADPH [1,2].
• Glutamine metabolism regulates ferroptosis sensitivity through transferrin and glutaminolysis.
• Hyperpolarized 13C/15N-glutamine probes enable non-invasive imaging of glutamine utilization in vivo.
• Altered glutamine metabolism is observed in type 1 and type 2 diabetes models.
• L-glutamine is used clinically for parenteral nutrition and gastrointestinal support.
• Industrial L-glutamine production uses Corynebacterium glutamicum engineered for high yield [4,5].
• Glutamine pathway genes are frequently amplified or overexpressed in multiple cancers [1,2].
• Targeting glutamine metabolism is a promising therapeutic strategy, with inhibitors in clinical trials.
• CRISPR-based models are critical for validating glutamine pathway targets and resistance mechanisms [1,2].
What Happens During L-glutamine metabolic process?
Glutamine Uptake and Transport
In simple terms: Cells take in glutamine from the outside using specialized transporter proteins.
Glutamine is imported into cells primarily via the alanine-serine-cysteine transporter 2 (ASCT2/SLC1A5) and other solute carriers [1,2]. This uptake is often upregulated in cancer cells to meet increased metabolic demand. The transport step is the first committed step of glutamine utilization and is a target for metabolic inhibitors.
Glutaminolysis: Deamidation to Glutamate
In simple terms: Glutamine is converted to glutamate by removing an ammonia group.
The enzyme glutaminase (GLS) catalyzes the hydrolysis of glutamine to glutamate and ammonia, a rate-limiting step in glutaminolysis [1,2]. GLS exists as two isoforms, GLS1 (kidney-type) and GLS2 (liver-type), with distinct tissue distributions and regulatory roles. This step is essential for providing glutamate for downstream metabolism.
Glutamate Dehydrogenation and TCA Cycle Anaplerosis
In simple terms: Glutamate is further processed to feed the energy-producing TCA cycle.
Glutamate dehydrogenase (GLUD1) converts glutamate to alpha-ketoglutarate (α-KG), which enters the TCA cycle for ATP production and anaplerosis [1,2]. Alternatively, transaminases such as GOT1 and GOT2 convert glutamate to α-KG while generating other amino acids. This branching is critical for redox balance and biosynthetic flexibility [1,2].
Glutamine Synthesis and Nitrogen Donation
In simple terms: Cells can also make glutamine and use it to donate nitrogen to other molecules.
Glutamine synthetase (GLUL) catalyzes the ATP-dependent condensation of glutamate and ammonia to form glutamine. Glutamine serves as a nitrogen donor for nucleotide biosynthesis (via amidotransferases), hexosamine biosynthesis, and amino acid synthesis [1,2]. This synthetic role is particularly important in liver and muscle.
Redox Homeostasis and Ferroptosis Regulation
In simple terms: Glutamine metabolism helps control oxidative stress and a type of iron-dependent cell death.
Glutamine-derived glutamate is used to synthesize glutathione (GSH), a major antioxidant [1,3]. Glutaminolysis and transferrin regulate ferroptosis, an iron-dependent form of cell death, by affecting labile iron pools and lipid peroxidation. This link has therapeutic implications for cancer and neurodegeneration.
Key Genes Involved in GO:0006541 L-glutamine metabolic process
The following genes encode enzymes, transporters, and regulators that directly participate in or control L-glutamine metabolic process (GO:0006541).
| Gene | Major Role | Research Relevance |
|---|---|---|
| GLS | Glutaminase; converts glutamine to glutamate | Rate-limiting enzyme in glutaminolysis; target in cancer therapy [1,2] |
| GLS2 | Liver-type glutaminase; glutamine catabolism | Isoform-specific roles in cancer and metabolism |
| GLUD1 | Glutamate dehydrogenase; glutamate to α-KG | Links glutamine metabolism to TCA cycle and insulin secretion |
| GLUL | Glutamine synthetase; synthesizes glutamine | Critical for nitrogen homeostasis and brain function |
| ASNS | Asparagine synthetase; uses glutamine as nitrogen donor | Implicated in asparaginase resistance in leukemia |
| GOT1 | Cytosolic aspartate aminotransferase | Supports redox balance in pancreatic cancer |
| GOT2 | Mitochondrial aspartate aminotransferase | Facilitates glutamine anaplerosis |
| SLC1A5 | Glutamine transporter (ASCT2) | Mediates glutamine uptake; target for inhibitors [1,2] |
| SLC7A5 | L-type amino acid transporter 1 (LAT1) | Exchanges glutamine for essential amino acids |
| SLC38A1 | Sodium-coupled neutral amino acid transporter 1 | Glutamine transport in neurons and cancer |
| SLC38A2 | Sodium-coupled neutral amino acid transporter 2 | Glutamine uptake in proliferating cells |
| GCLC | Glutamate-cysteine ligase catalytic subunit | Glutathione synthesis from glutamate |
| GCLM | Glutamate-cysteine ligase modifier subunit | Regulates glutathione synthesis |
| GPX4 | Glutathione peroxidase 4 | Lipid repair; ferroptosis suppression |
| TFRC | Transferrin receptor | Iron uptake; linked to glutaminolysis and ferroptosis |
| MYC | Oncogenic transcription factor | Drives glutamine metabolism gene expression [1,2] |
| ATF4 | Stress-responsive transcription factor | Regulates ASNS and glutamine metabolism under stress |
How Is L-glutamine metabolic process Regulated?
L-glutamine metabolic process is regulated at multiple levels. The oncogene MYC transcriptionally upregulates glutamine transporters and GLS, promoting glutamine addiction in cancer [1,2]. The transcription factor ATF4 mediates the integrated stress response and induces ASNS and other amino acid metabolic genes under glutamine limitation. mTORC1 signaling promotes glutamine uptake and metabolism to support cell growth. Additionally, GLS is regulated by alternative splicing and by oncogenic miRNAs. In diabetes, insulin and glucagon modulate hepatic glutamine metabolism, with altered flux observed in both type 1 and type 2 models. These regulatory layers make GO:0006541 a dynamic and context-dependent process [1,2].
L-glutamine metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GLS | Cancer (glutamine addiction) | GLS knockout in cancer cell lines; xenograft models [1,2] |
| GPX4 | Ferroptosis sensitivity | GPX4 knockout or point mutation; lipid peroxidation assays |
| TFRC | Ferroptosis and iron metabolism | TFRC knockdown; transferrin stimulation |
| GLUL | Hyperammonemia and brain edema | GLUL knockout mice; ammonia challenge |
| ASNS | Acute lymphoblastic leukemia (asparaginase resistance) | ASNS overexpression in leukemia cells |
Cancer Metabolism and Glutamine Addiction
Many cancer cells exhibit glutamine addiction, relying on glutaminolysis for survival and proliferation [1,2]. MYC-driven cancers upregulate GLS and glutamine transporters, and inhibition of glutaminase shows efficacy in preclinical models [1,2]. Glutamine metabolism also supports redox balance and resistance to oxidative stress. Targeting this pathway is a major therapeutic strategy, with clinical trials of GLS inhibitors underway.
Ferroptosis and Cell Death Regulation
Glutaminolysis and transferrin receptor-mediated iron uptake regulate ferroptosis, an iron-dependent form of cell death. Glutamine-derived glutamate is required for glutathione synthesis, and its depletion sensitizes cells to ferroptosis. This link has implications for cancer therapy and neurodegeneration, where ferroptosis contributes to cell loss.
Diabetes and Metabolic Disorders
L-glutamine metabolism is altered in diabetes, with tissue-specific changes in liver and other organs. In type 1 and type 2 diabetes models, glutamine flux and enzyme activities are dysregulated, contributing to hyperglycemia and metabolic stress. Glutamine supplementation has been studied for its metabolic effects in humans.
From L-glutamine metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GLS loss impair tumor growth? | GLS knockout cancer cell lines and xenografts [1,2] |
| Does a specific GLS point mutation alter catalytic activity? | Point-mutation knock-in via CRISPR |
| Can glutamine transporter overexpression drive proliferation? | SLC1A5 overexpression cell models |
| Does tagging endogenous GLS reveal its localization? | Knock-in of fluorescent or epitope tag at GLS locus |
| What genes mediate resistance to glutaminase inhibition? | Genome-wide CRISPR knockout library screening |
| How does glutamine flux change in diabetes? | Primary hepatocytes from diabetic rodent models |
How to Study the L-glutamine metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Metabolite abundance and isotope labeling | Quantify glutamine and downstream metabolites |
| Hyperpolarized 13C/15N MRI | Real-time glutamine flux in vivo | Tumor metabolism imaging |
| CRISPR knockout screens | Gene essentiality and synthetic lethality | Identify glutamine pathway dependencies |
| Enzyme activity assay | GLS or GLUD1 catalytic activity | Validate inhibitors or mutations |
| Western blot | Protein expression and modifications | Confirm knockout or overexpression |
| RNA-seq | Transcriptional changes | Assess pathway gene expression |
| Ferroptosis assays | Lipid peroxidation and cell death | Link glutaminolysis to ferroptosis |
| Glutamine uptake assay | Transport activity | Measure SLC1A5 function |
Metabolomics and Stable Isotope Tracing
Liquid chromatography-mass spectrometry (LC-MS) with 13C/15N-labeled glutamine enables tracing of glutamine-derived metabolites through glutaminolysis and the TCA cycle [1,6]. Hyperpolarized [5-13C,4,4-2H2,5-15N]-L-glutamine provides real-time in vivo metabolic annotation. These methods quantify flux and identify pathway bottlenecks [1,6].
CRISPR Screens and Functional Genomics
Genome-wide CRISPR knockout screens identify genes required for glutamine metabolism and resistance to glutaminase inhibitors. Pooled screens with glutamine deprivation or GLS inhibition reveal synthetic lethal interactions. These approaches are powerful for target discovery in GO:0006541.
Enzyme Activity Assays and Western Blotting
Glutaminase and glutamate dehydrogenase activities are measured using colorimetric or fluorometric assays. Western blotting detects protein expression and post-translational modifications of key enzymes. These methods validate CRISPR knockout or overexpression models.
In Vivo Imaging and Hyperpolarized MRI
Hyperpolarized 13C/15N-glutamine MRI visualizes glutamine utilization in tumors and other tissues non-invasively. This technique can assess treatment response to glutamine metabolism inhibitors. It bridges in vitro findings to in vivo physiology.
How CRISPR Can Be Used to Study GO:0006541 L-glutamine metabolic process
Knockout
CRISPR knockout of GLS, GLUD1, or SLC1A5 abolishes specific steps of L-glutamine metabolic process, enabling assessment of their roles in proliferation, redox balance, and ferroptosis [1,2,3]. Knockout cell lines are essential for validating drug targets and identifying compensatory pathways.
Point Mutation
Point mutations in GLS or GLUD1 can be introduced to mimic cancer-associated variants or to abrogate catalytic activity, allowing structure-function studies. Such models help distinguish enzymatic from non-enzymatic functions.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) or epitope tags at endogenous GLS or GLUL loci enables live-cell imaging and proteomic analysis of glutamine enzymes. Knock-in of mutant alleles can model disease-associated variants.
Overexpression
Overexpression of GLS, SLC1A5, or MYC in cell lines drives glutamine addiction and increases flux through GO:0006541, providing models for drug testing and resistance studies [1,2]. Overexpression models are also used to study metabolic reprogramming.
How EDITGENE Supports L-glutamine metabolic process Research
Researchers studying L-glutamine metabolic process-related genes often need to determine whether a candidate gene is causally involved in pathway regulation, disease progression, or therapeutic response. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for L-glutamine metabolic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| CPS1 Knockout HEK293 Cell Line | EDJ-KQ1984 | Human | 1373 | Details Get a Quote |
| UCP2 Knockout HEK293 Cell Line | EDJ-KQ2339 | Human | 7351 | Details Get a Quote |
| GLS Knockout HEK293 Cell Line | EDJ-KQ3970 | Human | 2744 | Details Get a Quote |
| BLOC1S6 Knockout HEK293 Cell Line | EDJ-KQ8488 | Human | 26258 | Details Get a Quote |
| GLS2 Knockout HEK293 Cell Line | EDJ-KQ8704 | Human | 27165 | Details Get a Quote |
| GLYATL1 Knockout HEK293 Cell Line | EDJ-KQ10864 | Human | 92292 | Details Get a Quote |
| NIT2 Knockout HEK293 Cell Line | EDJ-KQ11904 | Human | 56954 | Details Get a Quote |
| GLYATL1B Knockout HEK293 Cell Line | EDJ-KQ13612 | Human | 100287520 | Details Get a Quote |
| SIRT4 Knockout HEK293 Cell Line | EDJ-KQ15265 | Human | 23409 | Details Get a Quote |
| CPS1 Knockout A-549 Cell Line | EDJ-KQ21962 | Human | 1373 | Details Get a Quote |
| CPS1 Knockout HCT 116 Cell Line | EDJ-KQ21963 | Human | 1373 | Details Get a Quote |
| CPS1 Knockout HeLa Cell Line | EDJ-KQ21964 | Human | 1373 | Details Get a Quote |
| GLS2 Knockout HeLa Cell Line | EDJ-KQ34929 | Human | 27165 | Details Get a Quote |
| NIT2 Knockout HeLa Cell Line | EDJ-KQ39132 | Human | 56954 | Details Get a Quote |
| SIRT4 Knockout A-549 Cell Line | EDJ-KQ45954 | Human | 23409 | Details Get a Quote |
Displaying Records 1 To 15 Of 38 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About L-glutamine metabolic process
What is L-glutamine metabolic process (GO:0006541)?
It is the set of chemical reactions and pathways involving glutamine, including its synthesis, transport, and catabolism to glutamate and downstream metabolites.
What genes are involved in L-glutamine metabolic process?
Key genes include GLS, GLS2, GLUD1, GLUL, ASNS, GOT1, GOT2, SLC1A5, SLC7A5, and MYC, among others [1,2].
How is glutamine metabolism linked to cancer?
Many cancer cells rely on glutaminolysis for energy, redox balance, and biosynthesis, a phenomenon known as glutamine addiction [1,2].
What is glutaminolysis?
Glutaminolysis is the catabolic pathway that converts glutamine to glutamate, then to alpha-ketoglutarate, feeding the TCA cycle.
How does glutamine metabolism affect ferroptosis?
Glutaminolysis and transferrin regulate ferroptosis by influencing glutathione synthesis and iron availability.
Can glutamine metabolism be imaged in vivo?
Yes, hyperpolarized 13C/15N-labeled glutamine enables real-time imaging of glutamine utilization in vivo.
What is the role of GLS in glutamine metabolism?
GLS (glutaminase) catalyzes the conversion of glutamine to glutamate, a rate-limiting step in glutaminolysis.
How do CRISPR screens help study glutamine metabolism?
CRISPR knockout screens identify genes essential for glutamine metabolism and resistance to inhibitors, revealing new targets.
Is glutamine metabolism altered in diabetes?
Yes, studies in diabetic rat models show tissue-specific changes in glutamine metabolism.
What are the industrial applications of L-glutamine metabolism?
Metabolic engineering of Corynebacterium glutamicum is used for high-yield L-glutamine production [4,5].
Conclusion
L-glutamine metabolic process (GO:0006541) is a fundamental biological pathway with profound implications for cancer, diabetes, ferroptosis, and biotechnology. Its complexity and disease relevance make it a prime target for functional genomics and therapeutic development [1,2,3]. Advances in CRISPR modeling, metabolomics, and in vivo imaging continue to unravel the regulatory layers of this pathway [1,6]. EDITGENE's suite of CRISPR services empowers researchers to dissect glutamine metabolism with precision and speed, from knockout to overexpression and library screening [1,2].
References
- 1. Li T et al.. 2021. Glutamine Metabolism in Cancer.. Adv Exp Med Biol 1311:17-38 PMID: 34014532
- 2. Yang WH et al.. 2021. Enhancing the Efficacy of Glutamine Metabolism Inhibitors in Cancer Therapy.. Trends Cancer 7(8):790-804 PMID: 34020912
- 3. Gao M et al.. 2015. Glutaminolysis and Transferrin Regulate Ferroptosis.. Mol Cell 59(2):298-308 PMID: 26166707
- 4. Kusumoto I. 2001. Industrial production of L-glutamine.. J Nutr 131(9 Suppl):2552S-5S PMID: 11533312
- 5. Lv Q et al.. 2021. Enhancing l-glutamine production in Corynebacterium glutamicum by rational metabolic engineering combined with a two-stage pH control strategy.. Bioresour Technol 341:125799 PMID: 34425465
- 6. Eskandari R et al.. 2022. Hyperpolarized [5-(13)C,4,4-(2)H(2),5-(15)N]-L-glutamine provides a means of annotating in vivo metabolic utilization of glutamine.. Proc Natl Acad Sci U S A 119(19):e2120595119 PMID: 35512101
- 7. Comar JF et al.. 2016. The Metabolic Responses to L-Glutamine of Livers from Rats with Diabetes Types 1 and 2.. PLoS One 11(8):e0160067 PMID: 27490892
- 8. Ziegler TR et al.. 1990. Safety and metabolic effects of L-glutamine administration in humans.. JPEN J Parenter Enteral Nutr 14(4 Suppl):137S-146S PMID: 2119459
